Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-08-14

Clinical Trial Update: Radiofrequency for the Treatment of Peripheral Vascular Occlusive Disease of the Lower Extremities [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating radiofrequency treatment for peripheral vascular occlusive disease of the lower extremities has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vessix Vascular, Inc | Conditions: Peripheral Vascular Disease | Phase 2, Phase 3 | Status: WITHDRAWN